Is CDKN2A p.Arg19Gln (c.56G>A) pathogenic?

CDKN2A p.Arg19Gln (c.56G>A) is classified Uncertain significance in CDKN2A (ClinVar, Multiple submitters, 3 submitters; last evaluated 2024-02-28). Very rare (popmax 0.00168%, amr); Associated with hereditary neoplastic syndrome.

What condition is associated with CDKN2A p.Arg19Gln (c.56G>A)?

CDKN2A p.Arg19Gln (c.56G>A) is associated with hereditary neoplastic syndrome, familial melanoma (ClinVar).

How common is CDKN2A p.Arg19Gln (c.56G>A) in the general population?

CDKN2A p.Arg19Gln (c.56G>A) is very rare (popmax 0.00168%, amr) (gnomAD).

CDKN2A p.Arg19Gln

c.56G>A · rs748616717 · VCV642110

Uncertain significance Multiple submitters

Classification

Uncertain significance

ClinVar

Review

Multiple submitters ★★☆☆

ClinVar · 3 submitters

gnomAD v4.1

Rare

very rare (popmax 0.00168%, amr)

Conditions

hereditary neoplastic syndrome

Computational evidence

Protein change
Missense predictors do not apply to this variant type; conservation carries the signal.
REVEL	0.074	moderately benign-leaning
Splicing
SpliceAI	—	not assessed · no allele here is in the release
Constraint at this position
Conservation	phyloP 0.062	GERP -0.29, phastCons 0.004
Overall
CADD	17.45	PHRED · no single calibrated threshold — expert panels disagree

Population frequency

gnomAD v4.1 · exomes + genomes

Grpmax group 0.00168% Admixed American · 1/59,664 alleles

Filtering AF 0.000125% ClinGen BA1/BS1 input FAF95, joint · FAF99 9.1e-05%

Overall 0.000374% 6/1,603,876 alleles · very rare

Ancestry group	Frequency	1 in
Admixed Americangrpmax	0.00168%	59,664
European (non-Finnish)	0.000425%	235,229

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene: CDKN2A
Protein: p.Arg19Gln
Coding: c.56G>A
MANE Select: NM_000077 · reported on NM_058195
dbSNP: rs748616717
Type: single nucleotide variant
Location: chr9:21994276 (GRCh38)
Gene constraint: LOEUF 0.791 · pLI 0.62 · ClinGen HI 3/3 (gnomAD)
Structure: AlphaFold pLDDT 77.02 · 5 PDB
Residue 19: an α-helix; a UniProt-annotated variant site (in cmm2; loss of cdk4 binding); the 'interaction with cdk5rap3 and mdm2' region

Full CDKN2A gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

hereditary neoplastic syndrome — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatments

Also linked: familial melanoma

Similar variants

CDKN2A p.Arg19Leu Uncertain significance ★★ same residue
CDKN2A p.Ala19= Benign/Likely benign ★★ same residue
CDKN2A p.Arg19Ter Likely pathogenic ★ same residue
CDKN2A p.Ala19Asp Uncertain significance ★ ⚠ same residue
CDKN2A p.Ala19Ser Uncertain significance ★ ⚠ same residue
CDKN2A p.Ala19Thr Uncertain significance ★ ⚠ same residue
CDKN2A p.Arg19Pro Uncertain significance ★ same residue
CDKN2A p.Arg19= Likely benign ★ same residue

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/cdkn2a-p-arg19gln (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown